Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin

Por Levine, Mark N., Drummond, Michael F., Labelle, Roberta J.
Publicado em 1985

Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times

Por Parpia, Sameer, Julian, Jim A, Gu, Chushu, Thabane, Lehana, Levine, Mark N
Publicado em 2014

Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study

Por Parpia, Sameer, Thabane, Lehana, Julian, Jim A, Whelan, Timothy J, Levine, Mark N
Publicado em 2013

Uptake of an innovation in surgery: observations from the cluster-randomized Quality Initiative in Rectal Cancer trial

Por Simunovic, Marko, Coates, Angela, Smith, Andrew, Thabane, Lehana, Goldsmith, Charles H., Levine, Mark N.
Publicado em 2013

Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial

Por Francescutti, Valerie, Coates, Angela, Thabane, Lehana, Goldsmith, Charles H., Levine, Mark N., Simunovic, Marko
Publicado em 2013

Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer

Por Parpia, Sameer, Julian, Jim A, Thabane, Lehana, Gu, Chushu, Whelan, Timothy J, Levine, Mark N
Publicado em 2014

The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery

Por Simunovic, Marko, Goldsmith, Charles, Thabane, Lehana, McLeod, Robin, DeNardi, Franco, Whelan, Timothy J, Levine, Mark N
Publicado em 2008

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG...

Por Addison, Christina L., Pond, Gregory R., Cochrane, Brandy, Zhao, Huijun, Chia, Stephen K., Levine, Mark N., Clemons, Mark
Publicado no J Bone Oncol (2015)

Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival

Por Simunovic, Marko, Rempel, Eddy, Thériault, Marc-Erick, Baxter, Nancy N., Virnig, Beth A., Meropol, Neal J., Levine, Mark N.
Publicado em 2009

Surgical outcomes in women with ovarian cancer

Por Elit, Laurie M., Bondy, Susan J., Paszat, Lawrence P., Holowaty, Eric J., Thomas, Gillian M., Stukel, Therese A., Levine, Mark N.
Publicado em 2008

The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery

Por Simunovic, Marko, Coates, Angela, Goldsmith, Charles H., Thabane, Lehana, Reeson, Dana, Smith, Andrew, McLeod, Robin S., DeNardi, Franco, Whelan, Timothy J., Levine, Mark N.
Publicado em 2010

A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials

Por Spears, Melanie, Yousif, Fouad, Lyttle, Nicola, Boutros, Paul C., Munro, Alison F., Twelves, Chris, Pritchard, Kathleen I., Levine, Mark N., Shepherd, Lois, Bartlett, John MS.
Publicado no Oncotarget (2015)

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial

Por Spears, Melanie, Lyttle, Nicola, D'Costa, Alister, Chen, Bingshu E., Yao, Cindy Q., Boutros, Paul C., Burnell, Margot, Levine, Mark N., O'Brien, Patti, Shepherd, Lois, Bartlett, John M.S.
Publicado no Oncotarget (2016)

Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitax...

Por Burnell, Margot, Levine, Mark N., Chapman, Judith-Anne W., Bramwell, Vivien, Gelmon, Karen, Walley, Barbara, Vandenberg, Ted, Chalchal, Haji, Albain, Kathy S., Perez, Edith A., Rugo, Hope, Pritchard, Kathleen, O'Brien, Patti, Shepherd, Lois E.
Publicado em 2010

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

Por Cheang, Maggie C.U., Voduc, K. David, Tu, Dongsheng, Jiang, Shan, Leung, Samuel, K. Chia, Stephen, Shepherd, Lois E., Levine, Mark N., Pritchard, Kathleen I., Davies, Sherri, Stijleman, Inge J., Davis, Carole, Ebbert, Mark T. W., Parker, Joel S., Ellis, Matthew J., Bernard, Philip S., Perou, Charles M., Nielsen, Torsten O.
Publicado em 2012

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Por Lyman, Gary H., Bohlke, Kari, Khorana, Alok A., Kuderer, Nicole M., Lee, Agnes Y., Arcelus, Juan Ignacio, Balaban, Edward P., Clarke, Jeffrey M., Flowers, Christopher R., Francis, Charles W., Gates, Leigh E., Kakkar, Ajay K., Key, Nigel S., Levine, Mark N., Liebman, Howard A., Tempero, Margaret A., Wong, Sandra L., Somerfield, Mark R., Falanga, Anna
Publicado no J Clin Oncol (2015)

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

Por Cheang, Maggie C.U., Martin, Miguel, Nielsen, Torsten O., Prat, Aleix, Voduc, David, Rodriguez-Lescure, Alvaro, Ruiz, Amparo, Chia, Stephen, Shepherd, Lois, Ruiz-Borrego, Manuel, Calvo, Lourdes, Alba, Emilio, Carrasco, Eva, Caballero, Rosalia, Tu, Dongsheng, Pritchard, Kathleen I., Levine, Mark N., Bramwell, Vivien H., Parker, Joel, Bernard, Philip S., Ellis, Matthew J., Perou, Charles M., Di Leo, Angelo, Carey, Lisa A.
Publicado no Oncologist (2015)

Regional Nodal Irradiation in Early-Stage Breast Cancer

Por Whelan, Timothy J., Olivotto, Ivo A., Parulekar, Wendy R., Ackerman, Ida, Chua, Boon H., Nabid, Abdenour, Vallis, Katherine A., White, Julia R., Rousseau, Pierre, Fortin, Andre, Pierce, Lori J., Manchul, Lee, Chafe, Susan, Nolan, Maureen C., Craighead, Peter, Bowen, Julie, McCready, David R., Pritchard, Kathleen I., Gelmon, Karen, Murray, Yvonne, Chapman, Judy-Anne W., Chen, Bingshu E., Levine, Mark N.
Publicado no N Engl J Med (2015)